Masashi Nagata

2.3k total citations
101 papers, 1.7k citations indexed

About

Masashi Nagata is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Masashi Nagata has authored 101 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Masashi Nagata's work include Head and Neck Cancer Studies (11 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Cancer-related molecular mechanisms research (6 papers). Masashi Nagata is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Cancer-related molecular mechanisms research (6 papers). Masashi Nagata collaborates with scholars based in Japan, United States and India. Masashi Nagata's co-authors include Hideki Nakayama, Ryoji Yoshida, Masanori Shinohara, Kenta Kawahara, Bo Lönnerdal, Akiyuki Hirosue, Akimitsu Hiraki, Yuichiro Matsuoka, Takuya Tanaka and Junki Sakata and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Masashi Nagata

98 papers receiving 1.7k citations

Peers

Countries citing papers authored by Masashi Nagata

Since Specialization

Citations

This map shows the geographic impact of Masashi Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Nagata more than expected).

Fields of papers citing papers by Masashi Nagata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Nagata. The network helps show where Masashi Nagata may publish in the future.

Co-authorship network of co-authors of Masashi Nagata

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Nagata. A scholar is included among the top collaborators of Masashi Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Nagata. Masashi Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Olanzapine Overdose in a Two-Year-Old Girl Resulting in Both High Serum and Plasma Levels 2023 ·Cureus ·Koji Yokoyama, (unknown), Mitsukazu Mamada, Masashi Nagata	1
2	Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma 2020 ·Cancers ·Junki Sakata, Akiyuki Hirosue, Ryoji Yoshida, Yuichiro Matsuoka, Kenta Kawahara, Hidetaka Arita, Hikaru Nakashima, Tatsuro Yamamoto, Masashi Nagata, (unknown), (unknown), (unknown), K. Yamana, Ryo Toya, Ryuji Murakami, Yoshikazu Kuwahara, Manabu Fukumoto, Hideki Nakayama	8
3	Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method 2020 ·PLoS ONE ·Ryoji Yoshida, Masashi Nagata, Akiyuki Hirosue, Kenta Kawahara, (unknown), Masatoshi Hirayama, Nozomu Takahashi, Yuichiro Matsuoka, Junki Sakata, Hikaru Nakashima, Hidetaka Arita, Akimitsu Hiraki, Masanori Shinohara, Ken Kikuchi, Hideki Nakayama	2
4	Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy 2020 ·Oral Diseases ·Kenta Kawahara, Akimitsu Hiraki, Hidetaka Arita, (unknown), Akiyuki Hirosue, Yuichiro Matsuoka, Junki Sakata, (unknown), Hikaru Nakashima, (unknown), Masashi Nagata, Ryoji Yoshida, Masanori Shinohara, Hideki Nakayama	5
5	BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene 2020 ·British Journal of Cancer ·Tatsuro Yamamoto, Akiyuki Hirosue, (unknown), Ryoji Yoshida, Junki Sakata, Yuichiro Matsuoka, Kenta Kawahara, (unknown), Masashi Nagata, Nozomu Takahashi, Akimitsu Hiraki, Masanori Shinohara, Mitsuyoshi Nakao, Noriko Saitoh, Hideki Nakayama	24
6	Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy 2020 ·Translational Oncology ·Ryoji Yoshida, (unknown), Junki Sakata, Yuichiro Matsuoka, Akiyuki Hirosue, Kenta Kawahara, (unknown), (unknown), K. Yamana, Masashi Nagata, Daiki Fukuma, Ryo Toya, Ryuji Murakami, Akimitsu Hiraki, Masanori Shinohara, Hideki Nakayama	22
7	HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma 2019 ·International Journal of Molecular Sciences ·Junki Sakata, Akiyuki Hirosue, Ryoji Yoshida, Kenta Kawahara, Yuichiro Matsuoka, Tatsuro Yamamoto, (unknown), Masatoshi Hirayama, Nozomu Takahashi, Takuya Nakamura, Hidetaka Arita, Hikaru Nakashima, Masashi Nagata, Akimitsu Hiraki, Masanori Shinohara, Hideki Nakayama	34
8	Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol 2019 ·BMC Pediatrics ·Masatoshi Takagi, Chitose Ogawa, (unknown), Tomoko Iehara, (unknown), (unknown), (unknown), Kiyoshi Nobori, (unknown), Shuki Mizutani, Toshimi Kimura, Masashi Nagata, Masato Yasuhara, Kenichi Yoshimura, (unknown), Hajime Hosoi, Ryuji Koike	8
9	Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report 2017 ·Molecular and Clinical Oncology ·Kenta Kawahara, Akimitsu Hiraki, Ryoji Yoshida, Hidetaka Arita, Yuichiro Matsuoka, Toshio Yamashita, (unknown), Masashi Nagata, Akiyuki Hirosue, Daiki Fukuma, Hideki Nakayama	10
10	Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS 2014 ·Clinical Cancer Research ·Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno, Masatoshi Hirayama, Hideki Nakayama, Takuya Tanaka, Masashi Nagata, (unknown), Kenta Kawahara, Yoshihiro Nakagawa, Ryoji Yoshida, Akiyuki Hirosue, Hidenao Ogi, Akimitsu Hiraki, Hirofumi Jono, Akinobu Hamada, Koji Yoshida, Yasuharu Nishimura, Yusuke Nakamura, Masanori Shinohara	123
11	Angiosarcoma of the oral cavity: a clinicopathological study and a review of the literature 2014 ·International Journal of Oral and Maxillofacial Surgery ·Masashi Nagata, Yoshihiro Yoshitake, Hideki Nakayama, Ryoji Yoshida, Kenta Kawahara, Y. Nakagawa, Masanori Shinohara	19
12	Marginal Zinc Deficiency Negatively Affects Recovery from Muscle Injury in Mice 2014 ·Biological Trace Element Research ·(unknown), Masashi Nagata, (unknown)	20
13	A Case of Diffusely Infiltrative Squamous Cell Carcinoma of the Esophagus with Hydronephrosis and Rapid Progression after Neoadjuvant Chemotherapy 2013 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Masashi Nagata, Yasuhiro Tsubosa, Masahiro Niihara	1
14	Retention of bone strength by feeding of milk and dairy products in ovariectomized rats: involvement of changes in serum levels of 1alpha, 25(OH)2D3 and FGF23 2012 ·The Journal of Nutritional Biochemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Masashi Nagata, Ayako Nakane, Akira Yamaguchi, Tadahiro Iimura, Masae Goseki‐Sone	9
15	Selective inhibition of nuclear factor‐κB by nuclear factor‐κB essential modulator‐binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma 2011 ·Cancer Science ·Takuya Tanaka, Hideki Nakayama, Yoshihiro Yoshitake, Atsushi Irie, Masashi Nagata, Kenta Kawahara, (unknown), Ryoji Yoshida, Yoshihiro Nakagawa, Hidenao Ogi, Satoru Shinriki, Kazutoshi Ota, Akimitsu Hiraki, Tetsuro Ikebe, Yasuharu Nishimura, Masanori Shinohara	23
16	Nucleostemin affects the proliferation but not differentiation of oral squamous cell carcinoma cells 2011 ·Cancer Science ·Ryoji Yoshida, Tetsuhiro Fujimoto, Shinji Kudoh, Masashi Nagata, Hideki Nakayama, Masanori Shinohara, Takaaki Ito	15
17	Group Hospital Internship Conducted by Faculties of Pharmacy Schools 2008 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Masashi Nagata, Muneaki Hidaka, (unknown), Tomomi Iwakiri, (unknown), Kazuhiko Arimori, (unknown), Asuka Kawachi, Jin Tokunaga, Masami Yokota Hirai, Norito Takamura, Toshiro Motoya, Ryuichi Yamamoto	6
18	Evaluation of Bedside Training by Students in Kyushu University of Health and Welfare and Their View of Future Issues to be Addressed 2007 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Norito Takamura, (unknown), Toshiro Motoya, Masami Yokota Hirai, Masashi Nagata, Asuka Kawachi, (unknown), (unknown)	11
19	Evaluation of Oral Disintegration Time of Rapidly Disintegrating Tablets (RDTs) by In Vivo and In Vitro Disintegration Testing 2006 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Keishi Yamasaki, Masashi Nagata, Rie Sato, (unknown), (unknown), (unknown), Hiroshi Sekiya, Y. Kawano, Hiromi Sasaki, Muneaki Hidaka, Manabu Okumura, Kazuhiko Arimori	1
20	Artificial Fiber Complexes Composed of Cellulose and Guar Gum or Psyllium May Be Better Sources of Soluble Fiber for Rats than Comparable Fiber Mixtures 1994 ·Journal of Nutrition ·Hiroshi Hara, (unknown), Masashi Nagata, Masayuki Tsuji, (unknown), Shuhachi Kiriyama	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact